Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kerr

Showing results (651-660 of 671) with videos related to

Pageof 68
Sort By:
Nature Immunology|June 15, 2026
A temporal map of B cell diversification mechanisms in miceOliver P Skinner, Saba Asad, Marcela L Moreira, et al.
Science Advances|January 10, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cellsAhmed Z Gad, Jessica S Morris, Lea Godret-Miertschin, et al.
Physical Review Letters|March 21, 2015
Enhanced relativistic-electron-beam energy loss in warm dense aluminumX Vaisseau, A Debayle, J J Honrubia, et al.
Nature Medicine|June 10, 2021
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandC R Simpson, T Shi, E Vasileiou, et al.
Physical Review Letters|May 9, 2025
Direct Evidence of Multispecies Hydrodynamics in Ignition-Scale HohlraumsDrew P Higginson, N Izumi, M D Rosen, et al.
BMC Infectious Diseases|October 19, 2023
Hepatitis C virus prevalence among men who have sex with men: a cross-sectional study in 12 Brazilian citiesVanessa C M Silva, Lígia R F S Kerr, Carl Kendall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
JAMA Surgery|June 12, 2024
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical TrialMikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.
The Lancet. Oncology|April 4, 2018
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trialTimothy J Iveson, Rachel S Kerr, Mark P Saunders, et al.
Pageof 68

Showing results (651-660 of 671) with videos related to

Sort By:
Pageof 68
Nature Immunology|June 15, 2026
A temporal map of B cell diversification mechanisms in miceOliver P Skinner, Saba Asad, Marcela L Moreira, et al.
Science Advances|January 10, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cellsAhmed Z Gad, Jessica S Morris, Lea Godret-Miertschin, et al.
Physical Review Letters|March 21, 2015
Enhanced relativistic-electron-beam energy loss in warm dense aluminumX Vaisseau, A Debayle, J J Honrubia, et al.
Nature Medicine|June 10, 2021
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandC R Simpson, T Shi, E Vasileiou, et al.
Physical Review Letters|May 9, 2025
Direct Evidence of Multispecies Hydrodynamics in Ignition-Scale HohlraumsDrew P Higginson, N Izumi, M D Rosen, et al.
BMC Infectious Diseases|October 19, 2023
Hepatitis C virus prevalence among men who have sex with men: a cross-sectional study in 12 Brazilian citiesVanessa C M Silva, Lígia R F S Kerr, Carl Kendall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
JAMA Surgery|June 12, 2024
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical TrialMikail Gögenur, Andreas Weinberger Rosen, Timothy Iveson, et al.
The Lancet. Oncology|April 4, 2018
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trialTimothy J Iveson, Rachel S Kerr, Mark P Saunders, et al.
Pageof 68